SUNMED SUNWAY HEALTHCARE HOLDINGS BERHAD
SUNMED scores 51/100 on fundamentals: in the top 48% of 1120 scored Bursa Malaysia stocks. Its strongest area is Business Strength (75/100); its weakest is Price Fairness (0/100). It carries 2 warning flags: Weak Spot, Limited Data.
- Carries a Weak Spot flag
- Carries a Limited Data flag
Nearby peers
Ranks #14 of 30 in Health Care by score
One-Minute Summary
Why SUNMED scores 51
An expensively priced stock with healthy growth, but price fairness needs attention.
Business Strength
75Why 75?
Show 2 charts
Revenue & Net Profit, with Net Margin
Sales grew about 74% over 4 years: customers keep spending more with this company.
Profit climbed about 22.7% over 4 years: the business keeps more money as it grows.
Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)
Sales grew about 42% over the last 5 quarters: customers keep spending more with this company.
Profit grew about 101.5% over the last 5 quarters: the business is keeping more of what it earns.
Financial Safety
67Why 67?
Show 2 charts
Debt vs Equity, with D/E ratio
Borrowings grew about 3,368% over 4 years: watch this; rising debt adds pressure in bad times.
Short-term assets vs bills, with Current Ratio
Cash & Dividends
50Why 50?
Show 3 charts
Operating vs Free Cash Flow
The business generates real cash, and more of it each year: a very healthy sign.
Cash vs Total Debt
Dividends per Share, with Yield
Dividends per share have been maintained or raised: management shares the rewards with you.
Price FairnessLowest pillar
0Why 0?
Show chart
Share Price: Weekly Closes (not part of the score)
The share price is up about 10.5% since 2026.
What happened, and how the price moved
- 20 Aug 2026Sunway Healthcare's 2Q net profit surges 89% on higher patient volumes, record revenue · The Edge Malaysia +4 moreWeek▲5.0%KLCI +0.5%Month▲6.0%KLCI −2.4%
- 20 May 2026Sunway Healthcare’s maiden post-listing quarterly profit slips 14%, despite higher revenue · The Edge Malaysia +1 moreWeek▼3.2%KLCI −1.6%Month▼4.3%KLCI −3.3%
- 16 Mar 2026Sunway Healthcare logs 43% jump in quarterly profit ahead of Main Market debut · The Edge Malaysia +2 moreWeektoo recentMonthtoo recent
Risk
70Why 70?
Get an email when SUNMED's score changes, and why
Own more than one stock? Check them all at once ›Sector peers
SUNMED (5555.KL) scores 51/100 (Okay) on Score Your Stock's educational fundamentals model: in the top 48% of 1120 scored Bursa Malaysia stocks.
Its strongest pillar is Business Strength (75/100); its weakest is Price Fairness (0/100).
SUNMED ranks #14 of 30 scored Health Care stocks on Score Your Stock.
SUNMED (5555.KL) has not paid a dividend in the last 12 months.
Open a trading account and a CDS account with any Bursa Malaysia broker, then place a buy order for 5555.KL in lots of 100 shares. Broker fees for the same trade differ a lot between brokers: compare them for your trade size at https://scoreyourstock.com/tools/brokerage-fee-calculator.
The overall score pools every measure across 5 weighted pillars: Business Strength, Financial Safety, Cash & Dividends, Price Fairness, and Risk (for banks, Financial Safety checks impaired loans, loan loss coverage and the CET1 capital ratio instead of debt and liquidity). Full methodology, the default weights, and how to set your own: https://scoreyourstock.com/how. This is an educational tool, not investment advice.
Sunway's hospital arm, running Sunway Medical Centre hospitals, senior living and ambulatory care. On Score Your Stock's fundamentals check, it scores 51/100, rated Okay. Its biggest strength is Business Strength (75/100); its main watch-out is Price Fairness (0/100). Shares currently cost about 81 years of its current profit to buy (P/E 80.9×). Full breakdown and daily-updated score: https://scoreyourstock.com/stocks/klse/5555-sunmed
Full Financial History
Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.
| Financial Year | Revenue | Net Profit | Operating Cash Flow | Free Cash Flow | CapEx | Cash | Total Debt | Short-Term Debt | Equity | Current Assets | Current Liabilities | Total Assets | Total Liabilities | Inventory | Dividends | Return on Equity (ROE) | Net Profit Margin | Debt-to-Equity | Current Ratio | Interest Coverage | Dividend Payout Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | RM 551.7m | RM 1.6b | RM 306.1m | RM 2.5b | RM 1.1b | RM 905.5m | RM 4.8b | RM 2.3b | RM 91.4m | RM 0.0m | - | - | 0.7× | 1.2× | - | - |
| 2024 | RM 1.9b | RM 257.5m | RM 420.5m | RM -117.6m | RM -538.0m | RM 768.0m | RM 1.1b | RM 282.9m | RM 2.9b | RM 1.2b | RM 931.5m | RM 4.7b | RM 1.8b | RM 78.3m | RM 0.0m | 9% | 14% | 0.4× | 1.3× | 7.5× | 4% |
| 2023 | RM 1.5b | RM 181.6m | RM 294.2m | RM -597.2m | RM -891.4m | RM 45.7m | RM 710.5m | RM 310.9m | RM 2.6b | RM 963.8m | RM 841.2m | RM 3.9b | RM 1.3b | RM 65.6m | RM 0.0m | 7% | 12% | 0.3× | 1.2× | 13.2× | 5% |
| 2022 | RM 1.1b | RM 209.9m | RM 198.2m | RM -428.2m | RM -626.4m | RM 25.4m | RM 46.6m | RM 32.9m | RM 2.5b | RM 383.8m | RM 418.8m | RM 2.9b | RM 462.0m | RM 47.5m | RM 0.0m | 8% | 20% | 0.0× | 0.9× | 17.2× | 2% |